Pfizer 2Q Revenues: $11.7 billion (+3%) 2Q Earnings: $2.4 billion (-30%)* YTD Revenues: $23.5 billion (flat) YTD Earnings: $6.5 billion (+73%)** Comments: Lipitor, Celebrex, Geodon and Lyrica performed well in the quarter: Lipitor sales were up 9% to $3.1 billion; Celebrex sales were $471 million, up 17%; Geodon sales were up 14% to $165 million and Lyrica sales were $271 million, up 38%. The company received approval/launched four products: Zeven, Eraxis, Exubera, and Chant...